SC
MRK icon

Stolper & Co’s Merck MRK Stock Holding History

Stolper & Co’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4.58M Sell
31,490
-185
-0.6% -$25.6K 1.18% 27
2026
Q2 		$4.07M Buy
31,675
+24,128
+320% +$2.82M 1.05% 31
2026
Q1 		$2.35M Sell
7,547
-23,141
-75% -$2.67M 0.67% 46
2025
Q4 		$3.23M Buy
30,688
+406
+1% +$38.1K 0.95% 31
2025
Q3 		$2.54M Buy
30,282
+1,810
+6% +$149K 0.77% 38
2025
Q2 		$2.25M Buy
28,472
+2,109
+8% +$168K 0.74% 39
2025
Q1 		$2.37M Buy
26,363
+225
+0.9% +$21K 0.78% 38
2024
Q4 		$2.6M Buy
26,138
+271
+1% +$27.9K 0.87% 32
2024
Q3 		$2.94M Sell
25,867
-399
-2% -$47.4K 0.96% 30
2024
Q2 		$3.25M Sell
26,266
-257
-1% -$33.1K 1.14% 29
2024
Q1 		$3.5M Sell
26,523
-112
-0.4% -$13.8K 1.26% 29
2023
Q4 		$2.9M Sell
26,635
-504
-2% -$52.3K 1.17% 28
2023
Q3 		$2.79M Sell
27,139
-166
-0.6% -$17.9K 1.21% 30
2023
Q2 		$3.15M Sell
27,305
-397
-1% -$45.1K 1.33% 28
2023
Q1 		$2.95M Buy
27,702
+43
+0.2% +$4.64K 1.26% 28
2022
Q4 		$3.07M Sell
27,659
-5,641
-17% -$577K 1.35% 28
2022
Q3 		$2.87M Buy
33,300
+1,905
+6% +$170K 1.41% 25
2022
Q2 		$2.86M Buy
31,395
+647
+2% +$57.4K 1.34% 25
2022
Q1 		$2.52M Buy
30,748
+4,721
+18% +$372K 1.07% 29
2021
Q4 		$2M Sell
26,027
-3,649
-12% -$291K 0.89% 35
2021
Q3 		$2.23M Buy
29,676
+575
+2% +$43.7K 1.07% 30
2021
Q2 		$2.26M Buy
29,101
+4,601
+19% +$342K 1.07% 30
2021
Q1 		$1.8M Buy
24,500
+4,179
+21% +$308K 0.93% 31
2020
Q4 		$1.59M Sell
20,321
-3,277
-14% -$251K 0.89% 37
2020
Q3 		$1.87M Sell
23,598
-3,887
-14% -$304K 1.21% 25
2020
Q2 		$2.03M Sell
27,485
-1,860
-6% -$140K 1.32% 26
2020
Q1 		$2.15M Buy
+29,345
New +$2.31M 1.55% 23

Other funds holding MRK

Smead Capital Management
Smead Capital Management Phoenix, Arizona $4.71B AUM 32.07% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
MN Services Vermogensbeheer
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
Sarasin & Partners
Sarasin & Partners London, United Kingdom $8.93B AUM 11.81% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
Cacti Asset Management
Cacti Asset Management Atlanta, Georgia $1.89B AUM 58.55% 1-Year Est. Return
Sumitomo Mitsui DS Asset Management
Sumitomo Mitsui DS Asset Management Tokyo, Japan $14.8B AUM 30.39% 1-Year Est. Return
IFM Investors
IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return

Stolper & Co's MRK Position: Q3 2026 in Review

Stolper & Co reduced its Merck (MRK) stake by 0.58% in Q3 2026, selling an estimated $25.6K and leaving 31,490 shares worth $4.58M. The position accounts for 1.18% of the portfolio, ranked #27.

Stolper & Co first reported a position in MRK in Q1 2020 and has held it in 27 quarters since. 833 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Stolper & Co held 31,490 shares of Merck worth $4.58M as of Q3 2026.
  • Stolper & Co sold 185 Merck shares in Q3 2026, an estimated $25.6K.
  • Merck made up 1.18% of Stolper & Co's portfolio in Q3 2026, its #27 holding.
  • Stolper & Co first reported a position in Merck in Q1 2020 and has held it in 27 quarters since.
  • 833 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Stolper & Co's 13F filing for Q3 2026, filed 13 Oct 2026.